IP Verse

New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi) - EP4321157B1

PatentPatent Analysis

EP4321157

NOVARTIS
Application Number
EP23202190A
Filing Date
Aug 26, 2014
Status
Granted And Under Opposition
Sep 20, 2024
Grant Date
Oct 23, 2024
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3143995B2
EP3487881B1
EP3090730B9

Bibliography

The patent EP4321157B1 was granted to Novartis on Oct 23, 2024 following the initial filing on Aug 26, 2014 under the application number EP23202190A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (17)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

ALFRED E TIEFENBACHERJul 23, 2025ADMISSIBLE
BETAPHARM ARZNEIMITTELJul 23, 2025ADMISSIBLE
HAMM & WITTKOPPJul 23, 2025ADMISSIBLE
KRKAJul 23, 2025ADMISSIBLE
LANYON OPPOSITIONSJul 23, 2025ADMISSIBLE
POLPHARMAJul 23, 2025ADMISSIBLE
WUESTHOFF & WUESTHOFFJul 23, 2025ADMISSIBLE
BULLE DRJul 22, 2025ADMISSIBLE
DEVA HOLDINGJul 22, 2025ADMISSIBLE
TEVA PHARMACEUTICALSJul 22, 2025ADMISSIBLE
CAMULONJul 21, 2025ADMISSIBLE
ELPEN PHARMACEUTICALJul 21, 2025ADMISSIBLE
EGISJul 18, 2025ADMISSIBLE
DR SCHONJul 16, 2025ADMISSIBLE
SYNTHONJul 14, 2025ADMISSIBLE
GENERICS UKJul 1, 2025ADMISSIBLE
ZENTIVA KSJun 25, 2025ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents